Breaking news – Pagina 154 – AMD

Breaking news

Aprile 3, 2024 dario.olivero

Prevalence, safety, and metabolic control among danish children and adolescents with type 1 diabetes using open-source automated insulin delivery systems

Fagerberg AR, Borch L, Kristensen K, Hjelle JS
Diabetes Technol Ther. Pub. Online 25 Mar 2024.

Leggi

Marzo 28, 2024 dario.olivero

Sarcopenic obesity is part of obesity paradox in dementia development: evidence from a population-based cohort study

Zhang J, Na X, Li Z, et al.
BMC Med. 2024;22(1):133.

Leggi

Aprile 3, 2024 dario.olivero

A practical evidence-based approach to management of type 2 diabetes in children and young people (CYP): UK consensus

White B, Ng SM, Agwu JC, et al.
BMC Med. 2024;22(1):144.

Leggi

Marzo 28, 2024 dario.olivero

The INNODIA Type 1 Diabetes Natural History Study: a European cohort of newly diagnosed children, adolescents and adults

Marcovecchio ML, Hendriks AEJ, Delfin C, et al.
Diabetologia. Pub. Online 22 Mar 2024.

Leggi

Marzo 28, 2024 dario.olivero

Effectiveness and safety of empagliflozin: final results from the EMPRISE study

Htoo PT, Tesfaye H, Schneeweiss S, et al.
Diabetologia. Pub. Online 21 Mar 2024.

Leggi

Marzo 28, 2024 dario.olivero

Effect of tirzepatide on body fat distribution pattern in people with type 2 diabetes

Cariou B, Linge J, Neeland IJ, et al.
Diabetes Obes Metab. Pub. Online 26 Mar 2024.

Leggi

Marzo 28, 2024 dario.olivero

Sodium-glucose cotransporter-2 inhibitors and the risk of atrial fibrillation in patients with type 2 diabetes: a population-based cohort study

Eroglu TE, Coronel R, Souverein PC
Eur Heart J Cardiovasc Pharmacother. 2024;pvae022.

Leggi

Marzo 28, 2024 dario.olivero

The effect of glucagon-like peptide-1 receptor agonists on cardiac function and structure in patients with or without type 2 diabetes mellitus: An updated systematic review and meta-analysis

Zhang Y, Yang D, Jia Q, et al.
Diabetes Obes Metab. Pub. Online 26 Mar 2024.

Leggi

Marzo 28, 2024 dario.olivero

Comparison of estimated glomerular filtration rate change with sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists among people with diabetes: A propensity-score matching study

Suzuki Y, Kaneko H, Nagasawa H, et al.
Diabetes Obes Metab. Pub. Online 26 Mar 2024.

Leggi

Marzo 26, 2024 dario.olivero

EMA – The Committee for Medicinal Products for Human Use (CHMP) for the medicinal product Nustendi adopted a new indication as follows: Cardiovascular disease

21/03/2024

Leggi